NCCN 2012 Congress Webinar Series: Genitourinary Cancers™: Treatment of Advanced Bladder Cancer

September 5, 2012

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This activity is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Apply existing and emerging clinical research data to make evidence-based selection of front-line and subsequent therapy for treatment of advanced bladder cancer to maintain the best possible quality of life
  • Counsel patients on the appropriate treatment options for advanced bladder cancer
Additional information
Supporters: 

This activity is supported an independent educational grant from:

  • Abbott


This activity is supported by an educational donation provided by:

  • Amgen


This activity is supported by educational grants from:

  • Astellas
  • Pfizer
  • sanofi-aventis U.S.


The National Comprehensive Cancer Network® (NCCN®) appreciates that supporting companies recognize NCCN’s need for autonomy in the development of the content of NCCN resources. All NCCN content is produced completely independently.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
09/05/2012
Course expires: 
11/30/2012
Event starts: 
09/05/2012 - 1:00pm
Event ends: 
09/05/2012 - 2:00pm
Cost:
$0.00

Lance C. Pagliaro, MD
The University of Texas MD Anderson Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Accreditation Period

Course opens: 
09/05/2012
Course expires: 
11/30/2012

Price

Cost:
$0.00
Please login or register to take this course.